NPFCX
Price
$64.16
Change
+$0.58 (+0.91%)
Updated
Jun 26 closing price
Net Assets
152.59B
RNGCX
Price
$64.05
Change
+$0.63 (+0.99%)
Updated
Jun 26 closing price
Net Assets
38.27B
Interact to see
Advertisement

NPFCX vs RNGCX

Header iconNPFCX vs RNGCX Comparison
Open Charts NPFCX vs RNGCXBanner chart's image
American Funds New Perspective C
Price$64.16
Change+$0.58 (+0.91%)
VolumeN/A
Net Assets152.59B
American Funds New Economy R3
Price$64.05
Change+$0.63 (+0.99%)
VolumeN/A
Net Assets38.27B
NPFCX vs RNGCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
NPFCX vs. RNGCX commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NPFCX is a Buy and RNGCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NPFCX has more cash in the bank: 153B vs. RNGCX (38.3B). NPFCX (0.00) and RNGCX (0.00) have matching dividends . NPFCX was incepted earlier than RNGCX: NPFCX (24 years) vs RNGCX (23 years). NPFCX (1.48) is less costly to investors than RNGCX (1.06). RNGCX is a more actively managed with annual turnover of: 36.00 vs. NPFCX (24.00). NPFCX (250) and RNGCX (250) have matching initial minimum investment requirements. NPFCX annual gain was more profitable for investors over the last year : 9.81 vs. RNGCX (6.24). NPFCX return over 5 years is better than : 44.04 vs. RNGCX (40.28).
NPFCXRNGCXNPFCX / RNGCX
Total Expense Ratio1.481.06140%
Annual Report Gross Expense Ratio1.481.06140%
Fund Existence24 years23 years-
Gain YTD10.8129.900109%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets153B38.3B399%
Annual Yield % from dividends0.000.00-
Returns for 1 year9.816.24157%
Returns for 3 years37.3350.5674%
Returns for 5 years44.0440.28109%
Returns for 10 years74.0764.82114%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NBY0.600.03
+4.60%
NovaBay Pharmaceuticals
DEI15.090.49
+3.36%
Douglas Emmett
TRST33.080.80
+2.48%
TrustCo Bank Corp
DOX91.370.71
+0.78%
Amdocs Limited
CTNM4.01-0.58
-12.64%
Contineum Therapeutics